[MeMed in Med Tech News] Testing times: Combatting antibiotic misuse and antimicrobial resistance

Kfir Oved, chairman, co-founder and CTO of MeMed Diagnostics, writes about the development of its new technology aiming to combat antibiotic misuse and antimicrobial resistance (AMR).

Read more here.

The post [MeMed in Med Tech News] Testing times: Combatting antibiotic misuse and antimicrobial resistance appeared first on OurCrowd Blog.

OurCrowd Blog

Anyone know the procedure and approximate prices for shelf life testing pre packaged food? (UK)

I’m starting a Hot Sauce company and I’m wondering how I can get my sauces tested to calculate the expiry date?

What I imagine happens is that we make a batch, bottle it and send a bottle to somewhere. They give us the expiry date which we then put on the rest of the bottles from that batch.

Is this right? Does anyone have recommendations on where I can get tests?

submitted by /u/ACertainShadeOfRed
[link] [comments]
Startups – Rapid Growth and Innovation is in Our Very Nature!

Carbon Health to launch 100 pop-up COVID-19 testing clinics across the U.S.

Primary care health tech startup Carbon Health has added a new element to its “omnichannel” healthcare approach with the launch of a new pop-up clinic model that is already live in San Francisco, LA, Seattle, Brooklyn and Manhattan, with Detroit to follow soon – and that will be rolling out over the next weeks and months across a variety of major markets in the U.S., ultimately resulting in 100 new COVID-19 testing sites that will add testing capacity on the order of around an additional 100,000 patients per month across the country.

So far, Carbon Health has focused its COVID-19 efforts around its existing facilities in the Bay Area, and also around pop-up testing sites set up in and around San Francisco through collaboration with genomics startup Color, and municipal authorities. Now, Carbon Health CEO and co-founder Even Bali tells me in an interview that the company believes the time is right for it to take what it has learned and apply that on a more national scale, with a model that allows for flexible and rapid deployment. In fact, Bali says the they realized and began working towards this goal as early as March.

“We started working on COVID response as early as February, because we were seeing patients who are literally coming from Wuhan, China to our clinics,” Bali said. “We expected the pandemic to hit any time. And partially because of the failure of federal government control, we decided to do everything we can to be able to help out with certain things.”

That began with things that Carbon could do locally, more close to home in its existing footprint. But it was obvious early on to Bali and his team that there would be a need to scale efforts more broadly. To do that, Carbon was able to draw on its early experience.

“We have been doing on-site, we have been going to nursing homes, we have been working with companies to help them reopen,” he told me. “At this point, I think we’ve done more than 200,000 COVID tests by ourselves. And I think I do more than half of all the Bay Area, if you include that the San Francisco City initiative is also partly powered by Carbon Health, so we’re already trying to scale as much as possible, but at some point we were hitting some physical space limits, and had the idea back in March to scale with more pop-up, more mobile clinics that you can actually put up like faster than a physical location.”

Interior of one of Carbon Health’s COVID-19 testing pop-up clinics in Brooklyn.

To this end, Carbon Health also began using a mobile trailer that would travel from town to town in order to provide testing to communities that weren’t typically well-served. That ended up being a kind of prototype of this model, which employs construction trailers like you’d see at a new condo under development acting as a foreman’s office, but refurbished and equipped with everything needed for on-site COVID testing run by medical professionals. These, too, are a more temporary solution, as Carbon Health is working with a manufacturing company to create a more fit-for-purpose custom design that can be manufactured at scale to help them ramp deployment of these even faster.

Carbon Health is partnering with Reef Technologies, a SoftBank -backed startup that turns parking garage spots into locations for businesses, including foodservice, fulfilment, and now Carbon’s medical clinics. This has helped immensely with the complications of local permitting and real estate regulations, Bali says. That means that Carbon Health’s pop-up clinics can bypass a lot of the red tape that slows the process of opening more traditional, permanent locations.

While cost is one advantage of using this model, Bali says that actually it’s not nearly as inexpensive as you might think relative to opening a more traditional clinic – at least until their custom manufacturing and economies of scale kick in. But speed is the big advantage, and that’s what is helping Carbon Health look ahead from this particular moment, to how these might be used either post-pandemic, or during the eventual vaccine distribution phase of the COVID crisis. Bali points out that any approved vaccine will need administration to patients, which will require as much, if not more infrastructure than testing.

Exterior of one of Carbon Health’s COVID-19 testing pop-up clinics in Brooklyn.

Meanwhile, Carbon Health’s pop-up model could bridge the gap between traditional primary care and telehealth, for ongoing care needs unrelated to COVID.

“A lot of the problems that telemedicine is not a good solution for, are the things where a video check-in with a doctor is nearly enough, but you do need some diagnostic tests – maybe you might you may need some administration, or you may need like a really simple physical examination that nursing staff can do with the instructions of the doctor. So if you think about those cases, pretty much 90% of all visits can actually be done with a doctor on video, and nursing staff in person.”

COVID testing is an imminent, important need nationwide – and COVID vaccine administration will hopefully soon replace it, with just as much urgency. But even after the pandemic has passed, healthcare in general will change dramatically, and Carbon Health’s model could be a more permanent and scalable way to address the needs of distributed care everywhere.

Startups – TechCrunch

Danish drone startup QuadSAT raises €2 million to boost its antenna testing tech

QuadSAT, a Danish company that is revolutionising thetest and measurement of satellite antennas, announced today that it has closed a €2 million Pre-Series A Investment, one of the largest venture investments in a Danish drone tech company. The round was led by Seraphim Capital, the world’s first venture fund dedicated to SpaceTech, Vaekstfonden, the Danish…

This content is for members only. Visit the site and log in/register to read.

EU-Startups

Diffblue launches a free community edition of its automated Java unit testing tool

Diffblue, a spin-out from Oxford University, uses machine learning to help developers automatically create unit tests for their Java code. Since few developers enjoy writing unit tests to ensure that their code works as expected, increased automation doesn’t just help developers focus on writing the code that actually makes a difference but also lead to code with fewer bugs. Current Diffblue customers include the likes of Goldman Sachs and AWS.

So far, Diffblue only offered its service through a paid — and pricey — subscription. Today, however, the company also launched its free community edition, Diffblue Cover: Community Edition, which doesn’t feature all of the enterprise features in its paid versions, but still offers an IntelliJ plugin and the same AI-generated unit tests as the paid editions.

The company also plans to launch a new lower cost ‘individual’ plan for Diffblue Cover soon, starting at $ 120 per month. This plan will offer access to support and other advanced features as well.

At its core, Diffblue uses unsupervised learning to build these unit tests. “What we’re doing is unique in the sense that there have been tools before that use what’s called static analysis,” Diffblue CEO Mathew Loge, who joined the company about a year ago, explained. “They look at the program and they basically understand the path through the program and try and work backwards from the path. So if the path gets to this point, what inputs do we need to put into the program in order to get here?” That approach has its limitations, though, which Diffblue’s reinforcement learning method aims to get around.

Once the process has run its course, Diffblue provides developers with readable tests. That’s important, Loge stressed, because if a test fails and a developer can’t figure out what happened, it’s virtually impossible for the developer to fix the issue. That’s something the team learning the hard way, as early version so Diffblue used a very aggressive algorithm that provided great test coverage (the key metric for unit tests), but made it very hard for developers to figure out what was happening.

With the community edition, which doesn’t offer the command-line interface (CLI) of Diffblue’s paid editions, developers can write their code in IntelliJ as before and then simply click a button to have Diffblue write the tests for that code.

“The Community Edition is designed to be very accessible. It is literally one click in the IDE and you get your tests. The CLI version is more sophisticated and it covers more cases and solves for teams and large deployments inside of an organization,” Loge explained.

The company plans to add support for other languages, including Python, JavaScript and C# over time, but as Loge noted, Java has long been a mainstay in the business world and the team felt like that would be the best language to start with. As Loge noted, though, the technology

Diffblue has actually been around for a bit. The company raised a $ 22 million Series A round led by Goldman Sachs and with participation from Oxford Sciences Innovation and the Oxford Technology and Innovations Fund in 2017. You obviously don’t raise that kind of money to focus only on unit tests for Java code. Besides support for more language, unit tests are just the first step in the company’s overall goal of automating more of the programming process with the help of AI.

“We started with testing because it’s an important and urgent problem, especially with the impact that it has on DevOps and the adoption of more rapid software cycles,” Loge said. The next obvious step is to then take a similar approach to automatically fixing bugs — and especially security bugs — in code as well.

“The idea is that there are these steppingstones to machines writing more and more code,” he said. “And also, frankly, it’s a way of getting developers used to that. Because developer acceptance is a crucial part of making this successful.”

Startups – TechCrunch

Zurich-based medtech startup Bloom Diagnostics wants to make blood testing easier and affordable

Based out of Zurich, Bloom Diagnostics develop devices that help users to keep a track, maintain, and improve their health. Recently, the company launched it’s testing device – ‘Blood System’, post-closing funding of €10 million Series B round back this May. 

Secure personal medical data

The company is on a mission to receive and secure personal medical data in a fast, affordable, and understandable way. The ‘Bloom System’ is designed specifically for patient use. The Bloom Test strips (pin-prick blood samples) are captured in a test strip and analysed in Bloom Lab. As per the company claims, it is maintenance-free by design and can be easily cleaned and updated when necessary.

Cloud solution developed over many years

The Bloom App explains the meaning of test results in a personalised, detailed report with actionable information. When a user performs a measurement, Bloom Analytics calibrates the raw measurement data on production-based calibration curves to deliver maximum accuracy. It then connects the results with self-reported symptoms to generate the medical analysis, which the Bloom App presents to the user, fully anonymously. 

It’s worth mentioning that Bloom Analytics is Bloom Diagnostics’ custom cloud solution developed over many years in close co-operation between medical experts, biotech specialists, cryptography enthusiasts, and production professionals.

“There is a need for a tertiary layer of diagnostic devices between individuals and the traditional healthcare system. This layer has seen its inception with products like the first LFA-based pregnancy tests in the 1970s,” explains co-founder and Chief Product Officer Thomas Kupper. “We think it’s overdue that this layer develops into something much more elaborate, helping individuals gain insights into their health in a wide range of situations. Combining those insights, globally, anonymized and in real time, will generate improvements that benefit the public.”

Dr. Angelica Kohlmann and Thomas Kupper founded Bloom Diagnostics with its headquarters in Zurich in Switzerland and offices in Vienna and New York.

Main image credits: Bloom Diagnostics

The post Zurich-based medtech startup Bloom Diagnostics wants to make blood testing easier and affordable appeared first on Silicon Canals .

Startups – Silicon Canals

Zurich-based medtech startup Bloom Diagnostics wants to make blood testing easier and affordable

Based out of Zurich, Bloom Diagnostics develop devices that help users to keep a track, maintain, and improve their health. Recently, the company launched it’s testing device – ‘Blood System’, post-closing funding of €10 million Series B round back this May. 

Secure personal medical data

The company is on a mission to receive and secure personal medical data in a fast, affordable, and understandable way. The ‘Bloom System’ is designed specifically for patient use. The Bloom Test strips (pin-prick blood samples) are captured in a test strip and analysed in Bloom Lab. As per the company claims, it is maintenance-free by design and can be easily cleaned and updated when necessary.

Cloud solution developed over many years

The Bloom App explains the meaning of test results in a personalised, detailed report with actionable information. When a user performs a measurement, Bloom Analytics calibrates the raw measurement data on production-based calibration curves to deliver maximum accuracy. It then connects the results with self-reported symptoms to generate the medical analysis, which the Bloom App presents to the user, fully anonymously. 

It’s worth mentioning that Bloom Analytics is Bloom Diagnostics’ custom cloud solution developed over many years in close co-operation between medical experts, biotech specialists, cryptography enthusiasts, and production professionals.

“There is a need for a tertiary layer of diagnostic devices between individuals and the traditional healthcare system. This layer has seen its inception with products like the first LFA-based pregnancy tests in the 1970s,” explains co-founder and Chief Product Officer Thomas Kupper. “We think it’s overdue that this layer develops into something much more elaborate, helping individuals gain insights into their health in a wide range of situations. Combining those insights, globally, anonymized and in real time, will generate improvements that benefit the public.”

Dr. Angelica Kohlmann and Thomas Kupper founded Bloom Diagnostics with its headquarters in Zurich in Switzerland and offices in Vienna and New York.

Main image credits: Bloom Diagnostics

The post Zurich-based medtech startup Bloom Diagnostics wants to make blood testing easier and affordable appeared first on Silicon Canals .

Startups – Silicon Canals

[Neura in PR Newswire] Neura Deploys ViruScore First-Ever COVID-19 Predictive Testing Solution

Neura, the leader in AI-powered behavioral intelligence providing real-world insights for health organizations, governments, and consumer brands today announced the adoption of ViruScore™ COVID-19 predictive testing solution.

Read more here.

The post [Neura in PR Newswire] Neura Deploys ViruScore First-Ever COVID-19 Predictive Testing Solution appeared first on OurCrowd Blog.

OurCrowd Blog

[Neura in CTech] Israel-based Neura deploys the first-ever Covid-19 predictive testing solution

Neura Inc. has announced the adoption of ViruScore, its predictive testing solution for coronavirus (Covid-19). According to tests, the solution increased the testing capacity of medical professionals sixfold and produced results with a 98% accuracy rate.

Read more here.

The post [Neura in CTech] Israel-based Neura deploys the first-ever Covid-19 predictive testing solution appeared first on OurCrowd Blog.

OurCrowd Blog

NewsLetter: Revolutionizing Blood Tests + Covid-19 Tracking and Testing

$ 71M Round for Sight Diagnostics

OLO

OurCrowd portfolio company Sight Diagnostics raised $ 71M for Its OLO Blood Analyzer with participation from Koch Disruptive Technologies, Longliv Ventures and OurCrowd. Sight’s FDA-cleared technology is set to revolutionize blood analysis by providing a full blood count comparable to existing lab tests, within minutes, on the spot, from a small pinprick. The company is researching the detection of new diseases and blood factors affecting the severity of Covid-19. OurCrowd has been an investor in Sight Diagnostics since 2014.

Webinar Aug.12: Protecting Data in the Quantum Age

Join us this Wednesday, August 12th for our next webinar Protecting Your Data Encryption in the Age of Quantum Computing at 8:00AM PDT, 11:00AM EDT, 6:00PM IDT. Prof. Hagai Eisenberg, CSO, QuantLR will explain how the company’s technology securely protects and encrypts data against quantum computing threats. Dr. Tal David, head of the Israel National Quantum Initiative, will discuss how government, corporations and startups will each play a pivotal role in developing quantum infrastructure and mitigating the associated risks. 

Top Tech News

Bizzabo’s Pivot to Virtual Events

Alon Alroy, CMO of Bizzabo, tells the TechCrunch Ask-Me-Anything Series how Bizzabo rapidly became one of the leading event management companies for virtual events amid the coronavirus pandemic, and rapidly increased its revenues.

Covid-19 Testing Solution from Neura

Increased capacity & faster results: Neura deploys COVID19 testing solution. “Being able to identify high and low-risk groups, future outbreaks, and behavioral Super-Spreaders is crucial to government efforts to fight the virus. With the recent FDA approval of Covid-19 test pooling, Neura’s insights will go even further in helping to slow and break down the chain of infection.”

Singapore Trials Airobotics Contact Tracing Solution

Singapore’s police have been trialing two pilotless drones developed by Airobotics to help enforce social distancing measures aimed at containing the spread of Covid-19.

Cracking Online Education

MasterClass Focuses on Talent to Stand Out in Online Education. The company chose to “run towards the impossible” to break into the crowded online education space, says CEO and Co-Founder David Rogier.

Israeli Startups Raise $ 700M in July

Israeli tech companies, which raised a record $ 8.3 billion in 2019, have already raised almost $ 6 billion in the first seven months of 2020, despite the Covid-19 crisis.

Taranis to Expand in Asia After Raising $ 30M

“In Asia, the agriculture food industry is unable to keep up with the region’s burgeoning population growth and demand,”  says Taranis, announcing a major initiative in Asia following its $ 30M Series C finance in July. The company’s drone-based agricultural intelligence system provides data from analyzing ultra-high-resolution images of crops.

Watch the Latest from OurCrowd

Medical Innovation from the Gates Foundation

Dr. Ruth Atherton, Deputy General Counsel and Director at the Bill & Melinda Gates Foundation, updates the OurCrowd Pandemic Innovation Conference on efforts to help mitigate the coronavirus crisis by creating global access to medical innovation. Watch here.

 

Creating Global Access to Medical Innovation

 

 

 

Job Vacancies

Despite the coronavirus pandemic, there are open positions at our global portfolio companies. See some opportunities below:

Search and filter through OurTalent to find your next challenge.

 

 

The post NewsLetter: Revolutionizing Blood Tests + Covid-19 Tracking and Testing appeared first on OurCrowd Blog.

OurCrowd Blog